Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer (Q63818856)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer |
clinical trial |
Statements
Everest2 (English)
0 references
A Two Arm Phase II Study of FOLFIRI in Combination With Standard or Escalating Dose of Cetuximab as First Line Treatment of K-Ras Wild Type Metastatic Colorectal Cancer: Everest 2 (English)
0 references
December 2010
0 references
June 2016
0 references
375
0 references
18 year
0 references